Pregnancy Early Pregnancy

Developmental effects of progesterone and its derivatives

Scialli AR

Reproductive Toxicology (Elmsford, N.Y.), 2(1), 3-11, 1988
DOI 10.1016/s0890-6238(88)80003-0 PMID 2980398

RRM Academy Synopsis

Progesterone in pregnancy looks unlikely to raise birth defect risk

A 1988 review of animal and human studies found that controlled human studies of progesterone alone showed no rise in birth defects. Reports of harm came mostly from uncontrolled case reports. Others mixed in other hormones or had flawed designs.

Study at a glance, narrative review: Progesterone in pregnancy looks unlikely to raise birth defect risk
Study at a glance, narrative review: Progesterone in pregnancy looks unlikely to raise birth defect risk. Source: Scialli AR, 1988, PMID 2980398.

Key Findings

  • Of 195 collected case reports of female pseudohermaphroditism (genital masculinization in girls) linked to progestins, 161 followed testosterone derivatives and ten followed progesterone.
  • The Collaborative Perinatal Project covered more than 50,000 US pregnancies. Progesterone, used in 527 of them, showed no association with any birth defect, though progestins as a group did.
  • A controlled retrospective review of 24,000 Mayo Clinic records from 1936 to 1974 found 244 pregnancies exposed to progesterone and no increase in anomalies.
  • An Israeli study of more than 34,000 deliveries found 2754 pregnancies with genital bleeding. Of these, 1608 used progestins. Exposed and unexposed infants showed no difference in total birth defects.
  • Animal studies of progesterone itself were generally negative. Genital abnormalities appeared in rodent and primate offspring given high doses of medroxyprogesterone acetate, a progesterone-derived drug.

Interpretation

This is a 1988 narrative review. Scialli gathered animal and human studies on progesterone. Scialli weighed them without pooling the numbers. Scialli set aside reports that mixed progesterone with other hormones. Scialli also set aside reports that mislabeled progestins as progesterone. Controlled studies counted more than case reports. The author notes that controlled studies carry more weight than case reports. The findings support further study of progesterone's safety in pregnancy.

RRM Context

Restorative reproductive medicine keeps two terms apart. Progesterone is the hormone the body makes. Progestins are lab-made drugs with similar activity. The author writes that progestins might not carry the same likelihood of safety. Many older reports involved progestins made from testosterone.

Abstract

Progesterone, the naturally-occurring 21-carbon steroid produced by the corpus luteum of the ovary and by the placenta, plays an important role in re-production. It is not surprising, then, that it has been used extensively as a supplement in the treatment of disorders of fertility and pregnancy. For example, progesterone is necessary for maintenance of pregnancy in mammals, including humans, and has been given for threatened or habitual miscarriage. The relaxant effect of progesterone on smooth muscle, including that of the uterus, has led to administration of this agent for preterm labor. The effect of progesterone in preparing the endometrium for implantation of the blastocyst has given rise to use of this hormone after natural or induced ovulation to supplement the function of the corpus luteum. How well such treatments work has been argued for many years; however, the fact remains that large numbers of women of reproductive age have received this hormone. It is pertinent, then, to consider whether progesterone or similar agents exert adverse effects on embryo development.

Topics

By this author

Related research

Pregnancy › Early Pregnancy › Progesterone Support · Reproductive Endocrinology › Ovarian Hormones › Progesterone · Therapeutics › Hormonal Agents › Progesterone and Progestins
Anthony R. Scialli
Tony Scialli, A Scialli
PMID 2980398 2980398 DOI 10.1016/s0890-6238(88)80003-0 10.1016/s0890-6238(88)80003-0 Scialli et al. 1988, Scialli 1988